Posts

Morgan Stanley Cuts Arvinas (NASDAQ:ARVN) Price Target ...

Arvinas (NASDAQ:ARVN – Free Report) had its target price trimmed by Morgan Stanl...

FY2025 EPS Estimates for Sandstorm Gold Lowered by Analyst

Sandstorm Gold Ltd. (TSE:SSL – Free Report) – Stock analysts at National Bank Fi...

Morgan Stanley Cuts Arhaus (NASDAQ:ARHS) Price Target t...

Arhaus (NASDAQ:ARHS – Free Report) had its price objective cut by Morgan Stanley...

USD/INR rises as India-Pakistan top military officials ...

Read more on https://www.fxstreet.com

Unravelling SUI Network

Barclays Cuts Murphy Oil (NYSE:MUR) Price Target to $22.00

Murphy Oil (NYSE:MUR – Free Report) had its price target lowered by Barclays fro...

Johnson Controls International (NYSE:JCI) Price Target ...

Johnson Controls International (NYSE:JCI – Free Report) had its price target rai...

Barclays Lowers Innovex International (NYSE:INVX) Price...

Innovex International (NYSE:INVX – Free Report) had its price target lowered by ...

Montrose Environmental Group (NYSE:MEG) Price Target Ra...

Montrose Environmental Group (NYSE:MEG – Free Report) had its price objective li...

Morgan Stanley Forecasts Strong Price Appreciation for ...

Cloudflare (NYSE:NET – Free Report) had its target price hoisted by Morgan Stanl...

Piper Sandler Cuts Globus Medical (NYSE:GMED) Price Tar...

Globus Medical (NYSE:GMED – Free Report) had its target price reduced by Piper S...

Janus International Group (NYSE:JBI) Price Target Raise...

Janus International Group (NYSE:JBI – Free Report) had its target price raised b...

Lincoln National (NYSE:LNC) Stock Price Expected to Ris...

Lincoln National (NYSE:LNC – Free Report) had its target price raised by Barclay...

Barclays Forecasts Strong Price Appreciation for Mid-Am...

Mid-America Apartment Communities (NYSE:MAA – Free Report) had its target price ...

Needham & Company LLC Reaffirms Buy Rating for HubSpot ...

Needham & Company LLC reaffirmed their buy rating on shares of HubSpot (NYSE:HUB...

Raymond James Reaffirms “Strong-Buy” Rating for Haemone...

Raymond James restated their strong-buy rating on shares of Haemonetics (NYSE:HA...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.